← All companies

MLTX

MoonLake Immunotherapeutics

MLTX Nasdaq Pharmaceutical Preparations EDGAR ↗

$17.93

+0.53 +3.05%

Key statistics

from XBRL data in SEC filings

Market cap

$1.32B

Revenue (TTM)

—

Net income (TTM)

-$257M

EPS (TTM)

$-3.88

P/E ratio

—

Dividend yield

—

Free cash flow

-$196M

Cash

$298M

Total assets

$400M

Gross margin

—

52-week range

$5.95 – $62.75

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 15, 2026 8-K Entered a material agreement Jun 25, 2026 8-K Regulation FD disclosure; Other events Jun 22, 2026 8-K Director or officer change; Shareholder vote results Jun 9, 2026 8-K Entered a material agreement Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 11, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Director or officer change; Regulation FD disclosure; Other events Feb 23, 2026 8-K Other events Jan 8, 2026 8-K Entered a material agreement Nov 5, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 5, 2025 8-K Other events Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Regulation FD disclosure Apr 29, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Director or officer change Dec 18, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Regulation FD disclosure Sep 11, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Regulation FD disclosure; Other events Jun 10, 2024 8-K Shareholder vote results Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K/A Fiscal year ended 2023-12-31 May 7, 2024 8-K Regulation FD disclosure; Other events Mar 11, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Regulation FD disclosure Feb 26, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Results of operations (earnings release) Nov 14, 2023